| Actigall ®(ursodiol, USP) capsules |
PDF |
| ACTONEL® (risedronate sodium) tablets |
PDF |
| ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4% |
PDF |
| ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5% |
PDF |
| ACUVAIL® (ketorolac tromethamine ophthalmic solution) 0.45% |
PDF |
| ACZONE® (dapsone) Gel 5% |
PDF |
| ACZONE® (dapsone) Gel, 7.5% |
PDF |
| AeroChamber Plus® Flow-Vu® Anti-Static Valved Holding Chamber |
PDF |
| AeroChamber Plus® Flow-Vu® aVHC
Small Mask/Medium Mask |
PDF |
| ALOCRIL® (nedocromil sodium ophthalmic solution) 2% |
PDF |
| Alora (Estradiol Transdermal System, USP) |
PDF |
| ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% |
PDF |
| ANDRODERM® (testosterone transdermal system), for topical use CIII |
PDF |
| AquADEKs® Chewable Tablets (aqua-dex’) Multivitamin and Mineral Supplement |
PDF |
| Armour® Thyroid (thyroid tablets, USP) |
PDF |
| ASACOL® HD (mesalamine) delayed-release tablets, for oral use |
PDF |
| ATELVIA® (risedronate sodium) delayed-release tablets |
PDF |
| AVAGE® (tazarotene) Cream 0.1% |
PDF |
| AVYCAZ (ceftazidime and avibactam) for injection, for intravenous use |
PDF |
| AZELEX® (azelaic acid cream) 20% |
PDF |
| BENTYL (dicyclomine hydrochloride) capsules, for oral use, BENTYL (dicyclomine hydrochloride) tablets, for oral use, BENTYL (dicyclomine hydrochloride) injection, for intramuscular use |
PDF |
| BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5% |
PDF |
| BLEPH®-10 (sulfacetamide sodium ophthalmic solution, USP) 10% |
PDF |
| BLEPHAMIDE® (sulfacetamide sodium − prednisolone acetate ophthalmic suspension, USP) 10%/0.2% |
PDF |
| BLEPHAMIDE® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% |
PDF |
| BOTOX® (onabotulinumtoxinA) |
PDF |
| BOTOX® and BOTOX® Cosmetic Med Guide |
PDF |
| BOTOX® Cosmetic (onabotulinumtoxinA) |
PDF |
| Brevicon® (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg) |
PDF |
| BYSTOLIC® (nebivolol) tablets, for oral use |
PDF |
| BYVALSON (nebivolol and valsartan) tablets, for oral use |
PDF |
| CANASA® (mesalamine) rectal suppository |
PDF |
| CARAFATE® (sucralfate) Suspension |
PDF |
| CARAFATE® (sucralfate) Tablets |
PDF |
| Celexa® (citalopram hydrobromide) Tablets |
PDF |
| COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% |
PDF |
| Condylox ® Gel (podofilox gel) |
PDF |
| Cordran® Tape Flurandrenolide Tape, USP |
PDF |
| Crinone® (progesterone gel) |
PDF |
| DALVANCE (dalbavancin) for injection, for intravenous use |
PDF |
| DELZICOL (mesalamine) delayed-release capsules, for oral use |
PDF |
| ELESTAT® (epinastine HCl ophthalmic solution) 0.05% |
PDF |
| ENABLEX ® (darifenacin) extended-release tablets |
PDF |
| ESTRACE® (estradiol vaginal cream, USP, 0.01%) |
PDF |
| ESTROSTEP® Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*) |
PDF |
| femhrt® (norethindrone acetate/ethinyl estradiol tablets) |
PDF |
| Femring® (estradiol acetate vaginal ring) |
PDF |
| FETZIMA® (levomilnacipran) extended-release capsules, for oral use |
PDF |
| Fiorinal® (Butalbital, Aspirin, and Caffeine Capsules, USP) |
PDF |
| Fiorinal® with Codeine C-III (Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP) |
PDF |
| FLUTTER® Mucus Clearance Device |
PDF |
| FML FORTE® (fluorometholone ophthalmic suspension) 0.25% |
PDF |
| FML® (fluorometholone ophthalmic ointment) 0.1% |
PDF |
| FML® (fluorometholone ophthalmic suspension, USP) 0.1% |
PDF |
| GELNIQUE (oxybutynin chloride) 10% Topical Gel |
PDF |
| GENERESS Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) |
PDF |
| INFeD (Iron Dextran Injection USP) |
PDF |
| KADIAN® (morphine sulfate) extended-release capsules, for oral use, CII |
PDF |
| KYBELLA (deoxycholic acid) injection, for subcutaneous use |
PDF |
| LASTACAFT® (alcaftadine ophthalmic solution) 0.25% |
PDF |
| LATISSE® (bimatoprost ophthalmic solution) 0.03% |
PDF |
| Lexapro® (escitalopram oxalate) Tablets, Lexapro® (escitalopram oxalate) Oral Solution |
PDF |
| LILETTA (levonorgestrel-releasing intrauterine system) |
PDF |
| LILETTA® (levonorgestrel-releasing intrauterine system) SHI |
PDF |
| LINZESS (linaclotide) capsules, for oral use |
PDF |
| Lo Loestrin® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
| Lo Minastrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
| LUMIGAN® 0.01% (bimatoprost ophthalmic solution) |
PDF |
| MICROZIDE® (hydrochlorothiazide, USP) |
PDF |
| Minastrin®24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) |
PDF |
| MONUROL (fosfomycin tromethamine) sachet |
PDF |
| NAMENDA (memantine HCl) tablets, for oral use, NAMENDA (memantine HCl) solution, for oral use |
PDF |
| NAMENDA XR (memantine hydrochloride) extended release capsules, for oral use |
PDF |
| NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use |
PDF |
| NEPHRO-VITE®RX (Vitamin B Complex and C Supplement) |
PDF |
| NORCO® (Hydrocodone Bitartrate and Acetaminophen Tablets, USP) |
PDF |
| OCUFLOX® (ofloxacin ophthalmic solution) 0.3% |
PDF |
| OXYTROL (oxybutynin transdermal system) |
PDF |
| OZURDEX® (dexamethasone intravitreal implant) 0.7 mg |
PDF |
| POLYTRIM® (polymyxin B sulfate and trimethoprim ophthalmic solution, USP) |
PDF |
| PRED FORTE® (prednisolone acetate ophthalmic suspension, USP) 1% |
PDF |
| PRED MILD® (prednisolone acetate ophthalmic suspension, USP) 0.12% |
PDF |
| PRED-G® (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% |
PDF |
| PRED-G® (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% |
PDF |
| PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules |
PDF |
| RAPAFLO® (silodosin) capsules |
PDF |
| RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal use |
PDF |
| REFRESH CONTACTS® Contact Lens Comfort Drops |
PDF |
| RESTASIS MULTIDOSE™(cyclosporine ophthalmic emulsion) 0.05% |
PDF |
| RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% |
PDF |
| RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% and RESTASIS MULTIDOSE™(cyclosporine ophthalmic emulsion) 0.05% |
PDF |
| RHOFADE™ (oxymetazoline hydrochloride) cream, 1% |
PDF |
| SAPHRIS® (asenapine) sublingual tablets |
PDF |
| SARAFEM (fluoxetine hydrochloride tablets) |
PDF |
| Savella® (milnacipran HCl) Tablets |
PDF |
| TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) |
PDF |
| TAZORAC® (tazarotene) Cream 0.05% and 0.1% |
PDF |
| TAZORAC® (tazarotene) Gel 0.05% and 0.1% |
PDF |
| TEFLARO® (ceftaroline fosamil) for injection, for intravenous use |
PDF |
| Thyrolar Tablets (Liotrix Tablets, USP) *
Currently unavailable due to shortage of the T3 component. For medical/product related questions, please call +1-800-678-1605. |
PDF |
| TRELSTAR® (triptorelin pamoate for injectable suspension) |
PDF |
| URSO 250® (ursodiol) tablets, for oral use,URSO Forte® (ursodiol) tablets, for oral use |
PDF |
| VANIQA® (eflornithine hydrochloride) Cream, 13.9% |
PDF |
| VIBERZI (eluxadoline) tablets, for oral use, CIV |
PDF |
| VIIBRYD (vilazodone hydrochloride) tablets, for oral use |
PDF |
| VIOKACE (pancrelipase) tablets, for oral use |
PDF |
| VRAYLAR (cariprazine) capsules, for oral use
|
PDF |
| ZENPEP® (pancrelipase) delayed release capsules |
PDF |
| ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% |
PDF |